Elanco Animal Health Incorporated (ELAN) on Monday said the U.S. Food and Drug Administration (FDA) has approved label expansions for two of its leading canine prescription parasiticides, Credelio Quattro and Credelio.
The updated labels now include prevention of Lyme disease, achieved through the killing of black-legged ticks, as well as the treatment and control of longhorned tick infestations.
According to the Companion Animal Parasite Council tracker, more than 422,000 cases of Lyme disease in dogs have been reported so far this year, exceeding the total annual cases recorded in 2019.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.